Ralph Tyler is the FDA's chief counsel.


March 31, 2010 - Federal investigators found no evidence supporting charges by several doctors and scientists working for the U.S. Food and Drug Administration (FDA) that managers retaliated against them for not approving certain medical devices.

The employees also alleged managers "ordered, intimidated and coerced" the scientists to manipulate data during product reviews, particularly within the Center for Devices and Radiological Health (CDRH). They also said approvals were not documented appropriately, and that decisions were influenced by the industry or politicians.

In 2008 and 2009, a group of FDA doctors and scientists wrote to Congress complaining their jobs were affected after they had raised their concerns. They spoke publicly about overuse of radiological devices in treatment and testing, and said that use of some imaging machines poses the possibility of dangerously high doses of radiation for patients.

In a letter sent in October of 2008 to the House Energy and Commerce Committee Under, the whistleblowers said "managers at CDRH have demanded that physicians and scientists review regulatory submissions employing methods, and accepting evidence and conclusions, that are not scientifically proven and clinically validated."

A report issued on January 15, 2009 by the Government Accountability Office (GAO), the investigative arm of Congress responsible for enhancing the performance of all federal government agencies, concludes that the FDA has approved many medical devices that have never been shown to be safe or effective. The GAO report advises that immediate steps be taken to modify the review policy for medical devices defined as "higher risk."

For more information: energycommerce.house.gov/


Related Content

News | Radiology Education

The American Society of Radiologic Technologists (ASRT) has named 109 individuals from across the country to participate ...

Time February 24, 2026
arrow
Feature | Information Technology | Dhruv Chopra

Radiology is a cornerstone of modern medical diagnostics, but today it stands at an inflection point. Pressures ...

Time February 24, 2026
arrow
News | Radiology Business

The American Society of Radiologic Technologists (ASRT) will host a free Virtual Career Fair on March 17, from 4-7 p.m ...

Time February 20, 2026
arrow
News | Magnetic Resonance Imaging (MRI)

Feb. 19, 2026 — GE HealthCare recently announced 510(k) clearance of three new magnetic resonance (MR) innovations with ...

Time February 20, 2026
arrow
News | Breast Biopsy Systems

Feb. 18, 2026 — Mammotome, a Danaher company, has introduced the Mammotome Prima MR Dual Vacuum-Assisted Breast Biopsy ...

Time February 18, 2026
arrow
News | Breast Imaging

Feb. 16, 2026 — Rising demand for breast cancer screening and diagnostics is outpacing the supply of available breast ...

Time February 17, 2026
arrow
Feature | Artificial Intelligence

For the past decade, artificial intelligence's (AI) potential in healthcare has been synonymous with speed. In medical ...

Time February 16, 2026
arrow
News | ARRS

Feb. 11, 2026 —The American Roentgen Ray Society (ARRS) has announced the following radiologists, as well as their ...

Time February 13, 2026
arrow
News | Radiology Business

Feb. 3, 2026 — RadNet, Inc., a provider of high-quality, cost-effective outpatient diagnostic imaging services and ...

Time February 12, 2026
arrow
News | Magnetic Resonance Imaging (MRI)

Feb. 6, 2026 — A state-of-the-art intraoperative MRI (iMRI) has arrived at the University of Chicago Medicine, one of ...

Time February 06, 2026
arrow
Subscribe Now